Awareness, Care & Treatment In Obesity Management - An Observation in Switzerland

Obesity Clinical Trial

— ACTION-CH  

Official title:

Awareness, Care & Treatment In Obesity Management - An Observation in Switzerland

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05232786
• Other study ID #: DAS-005
• Secondary ID: U1111-1266-4398
• Status: Completed
• Start date: March 8, 2022
• Est. completion date: April 8, 2022

Study information

• Verified date: October 2022
• Source: Novo Nordisk A/S
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

ACTION Switzerland is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor. The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1152
• Est. completion date: April 8, 2022
• Est. primary completion date: April 8, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria:

People Living with Obesity:

1. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).

2. Male, female or other, aged above or equal to 18 years at the time of signing informed consent

3. Lives in Switzerland (minimum quota based on primary language: German, French and Italian to ensure adequate samples for sub-group analysis)

4. Current BMI of 30 Kg/m^2 or greater calculated based on self-reported height and weight

Health Care Professionals:

1. Informed consent before any study related activities (study-related activities are any procedure related to recording/collection of data according to protocol)

2. Male, female or other, aged above or equal to 18 years at the time of signing informed consent.

3. Physician

4. Dietitian who is a member of the SVDE ASDD (Swiss Association of Dietitians) and services covered by the compulsory health insurance

5. Primary Care Providers (PCPs) whose specialty is Family Practice, General Practice, General Internal Medicine (who is focused on primary care)

6. Non-PCP Specialties whose specialty is Obstetrics/Gynaecologists, Endocrinologists/Diabetologists. Psychiatrists, General Internal Medicine with focus on diabetes and/or obesity and bariatric surgeons who are involved in the management of obesity in addition to surgery

7. Practices in Switzerland

8. In clinical practice for greater than or equal to 2 years

9. Spends at least 50% time in direct patient care

10. Has seen at least 100 adult patients in past month (all physicians except psychiatrists) Has seen at least 10 patients with obesity (PCPs and General Internal Medicine with focus on Diabetes and/or obesity, Obstetrics/ Gynaecologists, Endocrinology/Diabetology or Bariatric surgery) or 5 patients with obesity (dietitians and psychiatrists) in past month needing weight management defined as: a patient with a BMI greater than or equal to 30 Kg/m^2 with or without comorbidities. Exclusion criteria:

People Living with Obesity:

1. Previous participation in this study. Participation is defined as having given online consent in this study

2. Currently pregnant

3. Participates in intense fitness or body building programs

4. Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months

5. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation

Health Care Providers:

1. Previous participation in this study. Participation is defined as having given informed consent in this study.

2. Unwillingness, inability, or language barriers precluding adequate understanding or cooperation.

Related Conditions & MeSH terms

• Obesity

Intervention

Other:
• No treatment given
No treatment given

Locations

Country	Name	City	State
Switzerland	Novo Nordisk Investigational Site	Zürich

Sponsors (1)

Lead Sponsor	Collaborator
Novo Nordisk A/S

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Weight loss motivators	Multi-select from defined list	At the time of survey response (Day 1)
Primary	Proportion of PLwO who made serious weight loss effort	Number of weight loss efforts; percentage of patients	At the time of survey response (Day 1)
Primary	Attitudes towards obesity and weight management and Interactions of PLwOs with HCPs	5-point Likert scales (e.g., agreement, impact, frequency); - Proportion of responses in each category will be reported.	At the time of survey response (Day 1)
Primary	Weight loss barriers	Multi-select from defined list	At the time of survey response (Day 1)
Primary	Weight loss management	Multi-select from defined list	At the time of survey response (Day 1)